会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Azaperylenes as organic semiconductors
    • 亚萘基作为有机半导体
    • US20090101890A1
    • 2009-04-23
    • US11919605
    • 2006-05-03
    • Frank BienewaldBeat SchmidhalterUlrich BerensHans Jurg Kirner
    • Frank BienewaldBeat SchmidhalterUlrich BerensHans Jurg Kirner
    • H01L51/00C07D471/04H01L51/40C07D409/14
    • C09B5/028C07D471/06H01L51/0067H01L51/0069H01L51/0071H01L51/0072H01L51/0512H01L51/0541H01L51/5012Y10S428/93
    • A novel semiconductor device comprises an azaperylene organic semiconductor of the formula I (I) wherein each of R1, R2, R3 and R4 independently is selected from H, unsubstituted or substituted alkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted alkynyl, unsubstituted or substituted aryl, halogen, Si(RH)3, XR6; or one or more of R1 and R2, R2 and R3, R3 and R4, together with the carbon atoms they are bonding to, form a saturated or unsaturated, unsubstituted or substituted carbocyclic or heterocyclic ring; R5 is OR7, SR7, NR7R8, unsubstituted or substituted alkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted alkynyl, or unsubstituted or substituted aryl; R6 is Si(R11)3, unsubstituted or substituted alkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted alkynyl, unsubstituted or substituted aryl; R7 is H, unsubstituted or substituted alkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted alkynyl, unsubstituted or substituted aryl; X is O, S, NR8; Rδ is H, unsubstituted or substituted alkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted alkynyl, unsubstituted or substituted aryl, R11 being C1-C20-alkyl or -alkoxy.
    • 一种新颖的半导体器件包括式I(I)的氮杂伯有机半导体,其中R1,R2,R3和R4各自独立地选自H,未取代或取代的烷基,未取代或取代的烯基,未取代或取代的炔基,未取代或取代的 芳基,卤素,Si(RH)3,XR6; 或R 1和R 2,R 2和R 3,R 3和R 4中的一个或多个与它们键合的碳原子一起形成饱和或不饱和的未取代或取代的碳环或杂环; R5是OR7,SR7,NR7R8,未取代或取代的烷基,未取代或取代的烯基,未取代或取代的炔基,或未取代或取代的芳基; R6是Si(R11)3,未取代或取代的烷基,未取代或取代的烯基,未取代或取代的炔基,未取代或取代的芳基; R 7为H,未取代或取代的烷基,未取代或取代的烯基,未取代或取代的炔基,未取代或取代的芳基; X是O,S,NR8; Rdelta是H,未取代或取代的烷基,未取代或取代的烯基,未取代或取代的炔基,未取代或取代的芳基,R11为C1-C20烷基或 - 烷氧基。
    • 3. 发明申请
    • Process for Preparing Flake-Form Pigments Based on Aluminium and on Sioz(Z=0.7-2.0)
    • 基于铝和锡氧化物制备片状颜料的方法(Z = 0.7-2.0)
    • US20070259182A1
    • 2007-11-08
    • US11659769
    • 2005-08-15
    • Patrice BujardUlrich Berens
    • Patrice BujardUlrich Berens
    • C09C1/64
    • C09D5/36B42D25/387B82Y30/00C01P2004/62C01P2004/64C01P2006/60C09C1/0015C09C1/0018C09C1/0021C09C1/0078C09C1/642C09C2200/1008C09C2200/1037C09C2200/1041C09C2200/1054C09C2200/301C09C2200/302C09C2200/303C09C2200/304C09C2200/308C09C2220/20C09D11/322Y10T428/2995
    • The present invention relates to process for the production of plane-parallel platelets, comprising the steps: a) vapour-deposition of a separating agent onto a carrier to produce a separating agent layer, b) vapour-deposition of at least one product layer onto the separating agent layer, and c) dissolution of the separating agent layer in a solvent and production of a suspension in which the at least one product layer is present in the form of plane-parallel platelets, wherein the separating agent is selected from the group consisting of anthracene, anthraquinone, acetamidophenol, acetylsalicylic acid, camphoric anhydride, benzimidazole, benzene-1,2,4-tricarboxylic acid, biphenyl-2,2-dicarboxylic acid, bis(4-hydroxyphenyl)sulfone, dihydroxyanthraquinone, hydantoin, 3-hydroxybenzoic acid, 8-hydroxyquinoline-5-sulfonic acid monohydrate, 4-hydroxycoumarin, 7-hydroxycoumarin, 3-hydroxynaphthalene-2-carboxylic acid, isophthalic acid, 4,4-methylene-bis-3-hydroxynaphthalene-2-carboxylic acid, naphthalene-1,8-dicarboxylic anhydride, phthalimide and its potassium salt, phenolphthalein, phenothiazine, saccharin and its salts, tetraphenylmethane, triphenylene, triphenylmethanol, and also mixtures of at least two of those substances, especially pentaerythritol, trimesic acid (=1,3,5 benzene tricarboxylic acid), DL-alanine, DL-valine, 2,6-diaminopurine, ascorbic acid, 1,3,5-benzenetricarboxylic acid, o-acetylsalicyclic acid, diphenic acid, terephthalic acid, pyrogallol, cyanuric acid, hexamethyltetramine (urotropin), fumaric acid, and 4-acetylbenzoic acid and also mixtures of at least two of those substances.
    • 本发明涉及生产平面平行血小板的方法,包括以下步骤:a)将分离剂气相沉积到载体上以产生分离剂层,b)将至少一种产物层蒸镀沉积到 分离剂层,以及c)将分离剂层溶解在溶剂中并制备其中至少一种产物层以平面平行血小板的形式存在的悬浮液,其中分离剂选自组 由蒽,蒽醌,乙酰氨基苯酚,乙酰水杨酸,樟脑酸酐,苯并咪唑,苯-1,2,4-三羧酸,联苯-2,2-二羧酸,双(4-羟基苯基)砜,二羟基蒽醌,乙内酰脲, 羟基苯甲酸,8-羟基喹啉-5-磺酸一水合物,4-羟基香豆素,7-羟基香豆素,3-羟基萘-2-羧酸,间苯二甲酸,4,4-亚甲基 - 双-3-羟基萘-2-羧酸 ,萘-1,8-二羧酸酐,邻苯二甲酰亚胺及其钾盐,酚酞,吩噻嗪,糖精及其盐,四苯基甲烷,三亚苯基,三苯基甲醇,以及这些物质中的至少两种的混合物,特别是季戊四醇,均苯三酸(= 1 ,3,5-苯三甲酸),DL-丙氨酸,DL-缬氨酸,2,6-二氨基嘌呤,抗坏血酸,1,3,5-苯三甲酸,邻乙酰基水杨酸,二苯酸,对苯二甲酸,连苯三酚,氰尿酸 ,六甲基四胺(urotropin),富马酸和4-乙酰基苯甲酸,以及这些物质中的至少两种的混合物。
    • 4. 发明授权
    • Isoxazoline derivatives as P N ligands
    • 异恶唑啉衍生物作为P N配体
    • US07081536B2
    • 2006-07-25
    • US10485839
    • 2002-08-01
    • Nicole EndCatherine StoesselUlrich BerensPier Giorgio Cozzi
    • Nicole EndCatherine StoesselUlrich BerensPier Giorgio Cozzi
    • C07D263/08
    • C07F15/065C07C29/143C07C45/29C07F9/65583C07F9/65586C07F15/004C07F15/0053C07F15/0066C07F15/008C07F15/0093C07F15/045C07C33/22
    • The invention relates to novel ligands of the phosphanylbenzothiophenyl-dihydroisoxazoline, phosphanyl-dihydrooxazolyl-indole and phosphanyl-dihydrooxazolyl-benzofuran type, especially compounds of formula I and mixtures of such compounds, wherein X is oxygen, sulfur, selenium or NQ, wherein Q is unsubstituted or substituted aryl, or alkyl or substituted alkyl; n is 0, 1, 2, 3 or 4; A1 and A2 are each an organic radical capable of bonding to phosphorus, especially unsubstituted or substituted alkyl, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted cycloalkyl, or —N(D)2 wherein D2 is alkyl or substituted alkyl; or A1 and A2 together with the bonding phosphorus atom form a ring, which may be unsubstituted or substituted; Y, Y′, Y″ and Y′″ are each independently of the other hydrogen or alkyl, substituted alkyl, unsubstituted or substituted aryl, or unsubstituted or substituted heterocyclyl, at least one of the radicals Y, Y′, Y″ or Y′″ being one of the mentioned radicals with the exception of hydrogen; and Z, when present, is a substituent, it being possible when a plurality of substituents Z is present for those substituents to be selected independently of one another, and to processes for their preparation, to novel precursors and intermediates, to complexes with the said ligands, to their preparation and to their use as catalysts in organic synthesis (especially asymmetric organic synthesis).
    • 本发明涉及膦酰基苯并噻吩基 - 二氢恶唑啉,膦基 - 二氢恶唑基 - 吲哚和膦基 - 二氢恶唑基 - 苯并呋喃型的新配体,特别是式I化合物及其混合物,其中X是氧,硫,硒或NQ,其中Q是 未取代或取代的芳基,或烷基或取代的烷基; n为0,1,2,3或4; A 1和A 2分别是能够与磷结合的有机基团,特别是未取代或取代的烷基,未取代或取代的芳基,未取代或取代的杂环基,未取代或取代的环烷基 或-N(D)2,其中D 2是烷基或取代的烷基; 或A 1和A 2与键合磷原子一起形成环,其可以是未取代的或取代的; Y,Y',Y“和Y”'各自独立地为另一个氢或烷基,取代的烷基,未取代或取代的芳基,或未取代或取代的杂环基,基团Y,Y',Y' '或Y''是除了氢之外的所提及的基团之一; 当存在时,Z是一个取代基,当对于那些彼此独立选择的那些取代基存在多个取代基Z,并且其制备方法,新的前体和中间体与所述的 配体,它们的制备和用作有机合成(特别是不对称有机合成)中的催化剂。
    • 8. 发明授权
    • Process for preparing flake-form pigments based on aluminum and on Sioz(Z=0.7-2.0) comprising forming a layer of separating agent
    • 用于制备基于铝和Sioz(Z = 0.7-2.0)的片状颜料的方法,包括形成一层分离剂
    • US07943194B2
    • 2011-05-17
    • US11659769
    • 2005-08-15
    • Patrice BujardUlrich Berens
    • Patrice BujardUlrich Berens
    • B05D3/00C23C16/06C23C16/28
    • C09D5/36B42D25/387B82Y30/00C01P2004/62C01P2004/64C01P2006/60C09C1/0015C09C1/0018C09C1/0021C09C1/0078C09C1/642C09C2200/1008C09C2200/1037C09C2200/1041C09C2200/1054C09C2200/301C09C2200/302C09C2200/303C09C2200/304C09C2200/308C09C2220/20C09D11/322Y10T428/2995
    • The present invention relates to process for the production of plane-parallel platelets, comprising the steps of: a) vapor-deposition of a separating agent onto a carrier to produce a separating agent 5 layer, b) vapor-deposition of at least one product layer onto the separating agent layer, and c) dissolution of the separating agent layer in a solvent and production of a suspension in which the at least one product layer is present in the form of plane-parallel platelets, wherein the separating agent is selected from the group consisting of anthracene, anthraquinone, acetamidophenol, acetylsalicylic acid, camphoric anhydride, benzimidazole, benzene-1,2,4-tricarboxylic acid, biphenyl-2,2-dicarboxylic acid, bis(4-hydroxyphenyl)sulfone, dihydroxyanthraquinone, hydantoin, 3-hydroxybenzoic acid, 8-hydroxyquinoline-5-sulfonic acid monohydrate, 4-hydroxycoumarin, 7-hydroxycoumarin, 3-hydroxynaphthalene-2-carboxylic acid, isophthalic acid, 4,4-methylene-bis-3-hydroxynaphthalene-2-carboxylic acid, naphthalene-1,8-dicarboxylic anhydride, phthalimide and its potassium salt, phenolphthalein, phenothiazine, saccharin and its salts, tetraphenylmethane, triphenylene, triphenylmethanol, and also mixtures of at least two of those substances, especially pentaerythritol (C(CH2OH)4), trimesic acid (=1,3,5 benzene tricarboxylic acid), DL-alanine, DL-valine, 2,6-20 diaminopurine, ascorbic acid, 1,3,5-benzenetricarboxylic acid, o-acetylsalicyclic acid, diphenic acid, terephthalic acid, pyrogallol, cyanuric acid, hexamethyltetramine (urotropin), fumaric acid, and 4-acetylbenzoic acid and also mixtures of at least two of those substances.
    • 本发明涉及平面平行血小板的生产方法,包括以下步骤:a)将分离剂气相沉积到载体上以产生分离剂5层,b)至少一种产物的气相沉积 层,并且c)将分离剂层溶解在溶剂中并产生其中至少一种产物层以平面平行血小板的形式存在的悬浮液,其中分离剂选自 由蒽,蒽醌,乙酰氨基苯酚,乙酰水杨酸,樟脑酸酐,苯并咪唑,苯-1,2,4-三羧酸,联苯-2,2-二羧酸,双(4-羟基苯基)砜,二羟基蒽醌,乙内酰脲, 3-羟基苯甲酸,8-羟基喹啉-5-磺酸一水合物,4-羟基香豆素,7-羟基香豆素,3-羟基萘-2-羧酸,间苯二甲酸,4,4-亚甲基 - 双-3-羟基萘-2-羧酸 一个 cid,萘-1,8-二羧酸酐,邻苯二甲酰亚胺及其钾盐,酚酞,吩噻嗪,糖精及其盐,四苯基甲烷,三亚苯基,三苯基甲醇,以及这些物质中的至少两种,特别是季戊四醇(C(CH 2 OH) 4),均苯三酸(= 1,3,5苯三羧酸),DL-丙氨酸,DL-缬氨酸,2,6-20二氨基嘌呤,抗坏血酸,1,3,5-苯三甲酸,邻乙酰基水杨酸,二苯酚 酸,对苯二甲酸,连苯三酚,氰尿酸,六甲基四胺(urotropin),富马酸和4-乙酰基苯甲酸,以及这些物质中的至少两种的混合物。